211 related articles for article (PubMed ID: 11762326)
1. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett's esophagus and adenocarcinoma of the gastrica cardia.
Conio M; Cameron AJ
Gastrointest Endosc; 2001 Dec; 54(6):799-801. PubMed ID: 11762326
[No Abstract] [Full Text] [Related]
2. Barrett's esophagus-is it bad for your health?
Falk GW
Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
[TBL] [Abstract][Full Text] [Related]
3. Letter to the editor regarding "Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead?".
DeMeester SR
Am J Gastroenterol; 2010 May; 105(5):1201-2; author reply 1202-3. PubMed ID: 20445513
[No Abstract] [Full Text] [Related]
4. Adenocarcinoma of the lower esophagus and the esophagogastric junction.
Potet F; Fléjou JF; Gervaz H; Paraf F
Semin Diagn Pathol; 1991 Aug; 8(3):126-36. PubMed ID: 1925120
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic precursor lesions in Barrett's esophagus.
Hornick JL; Odze RD
Gastroenterol Clin North Am; 2007 Dec; 36(4):775-96, v. PubMed ID: 17996790
[TBL] [Abstract][Full Text] [Related]
8. Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia.
Rugge M; Fassan M; Battaglia G; Parente P; Zaninotto G; Ancona E
Hum Pathol; 2009 Aug; 40(8):1206-7; author reply 1207-8. PubMed ID: 19616698
[No Abstract] [Full Text] [Related]
9. Beta 1 integrin expression in adenocarcinoma of Barrett's esophagus.
Bottger TC; Youssef V; Dutkowski P; Seifert J; Maschek H; Brenner W; Junginger T
Hepatogastroenterology; 1999; 46(26):938-43. PubMed ID: 10370643
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in Barrett's oesophagus.
Dias Pereira A; Suspiro A; Chaves P
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
[TBL] [Abstract][Full Text] [Related]
12. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
13. Where are you and how do we find you? The dilemma of identifying Barrett's epithelium before adenocarcinoma of the esophagus.
Wong RK; Altekruse SF
Am J Gastroenterol; 2009 Jun; 104(6):1363-5. PubMed ID: 19436281
[TBL] [Abstract][Full Text] [Related]
14. Controversies of the cardiac mucosa and Barrett's oesophagus.
Lombard C
Histopathology; 2006 Jul; 49(1):97-8; author reply 98. PubMed ID: 16842257
[No Abstract] [Full Text] [Related]
15. Targeting surveillance in Barrett's esophagus.
Hillman L
J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
[No Abstract] [Full Text] [Related]
16. [Barrett and stomach carcinoma: surgical guidelines].
Hölscher AH; Bollschweiler E; Beckurts KT; Schneider PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():304-11. PubMed ID: 9931630
[TBL] [Abstract][Full Text] [Related]
17. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
Morgan G
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
[No Abstract] [Full Text] [Related]
18. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
Stein HJ; von Rahden BH; Höfler H; Siewert JR
Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
[TBL] [Abstract][Full Text] [Related]
20. Barrett esophagus: diagnostic challenges.
Hagen CE; Lauwers GY; Mino-Kenudson M
Semin Diagn Pathol; 2014 Mar; 31(2):100-13. PubMed ID: 24815936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
